142 related articles for article (PubMed ID: 28380302)
1. Discrepancy Between Tumor Antigen Distribution and Radiolabeled Antibody Binding in a Nude Mouse Xenograft Model of Human Melanoma.
Kim YI; Paeng JC; Cheon GJ; Kang KW; Lee DS; Chung JK
Cancer Biother Radiopharm; 2017 Apr; 32(3):83-89. PubMed ID: 28380302
[TBL] [Abstract][Full Text] [Related]
2. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
4. Melanoma localization in nude mice with monoclonal Fab against p97.
Beaumier PL; Krohn KA; Carrasquillo JA; Eary J; Hellström I; Hellström KE; Nelp WB; Larson SM
J Nucl Med; 1985 Oct; 26(10):1172-9. PubMed ID: 4045562
[TBL] [Abstract][Full Text] [Related]
5. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
[TBL] [Abstract][Full Text] [Related]
6. Dynamic interaction of 111indium-labeled monoclonal antibodies with surface antigens of solid tumors visualized in vivo by external scintigraphy.
Hwang KM; Keenan AM; Frincke J; David G; Pearson J; Oldham RK; Morgan AC
J Natl Cancer Inst; 1986 May; 76(5):849-55. PubMed ID: 3457973
[TBL] [Abstract][Full Text] [Related]
7. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
8. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
[TBL] [Abstract][Full Text] [Related]
9. Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibody.
Mann BD; Cohen MB; Saxton RE; Morton DL; Benedict WF; Korn EL; Spolter L; Graham LS; Chang CC; Burk MW
Cancer; 1984 Oct; 54(7):1318-27. PubMed ID: 6467157
[TBL] [Abstract][Full Text] [Related]
10. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
Hwang KM; Fodstad O; Oldham RK; Morgan AC
Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
[TBL] [Abstract][Full Text] [Related]
11. Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors.
Repetto-Llamazares A; Abbas N; Bruland ØS; Dahle J; Larsen RH
Anticancer Res; 2014 Jul; 34(7):3263-9. PubMed ID: 24982330
[TBL] [Abstract][Full Text] [Related]
12. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
14. Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography.
Del Vecchio S; Reynolds JC; Blasberg RG; Neumann RD; Carrasquillo JA; Hellström I; Larson SM
Cancer Res; 1988 Oct; 48(19):5475-81. PubMed ID: 3046739
[TBL] [Abstract][Full Text] [Related]
15. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy.
Fawwaz RA; Wang TS; Srivastava SC; Rosen JM; Ferrone S; Hardy MA; Alderson PO
J Nucl Med; 1984 Jul; 25(7):796-9. PubMed ID: 6737078
[TBL] [Abstract][Full Text] [Related]
16. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
[TBL] [Abstract][Full Text] [Related]
18. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in xenografted athymic mice.
Faguet GB; Agee JF
Leuk Lymphoma; 1997 May; 25(5-6):509-20. PubMed ID: 9250822
[TBL] [Abstract][Full Text] [Related]
19. 124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.
Zou P; Povoski SP; Hall NC; Carlton MM; Hinkle GH; Xu RX; Mojzisik CM; Johnson MA; Knopp MV; Martin EW; Sun D
World J Surg Oncol; 2010 Aug; 8():65. PubMed ID: 20691066
[TBL] [Abstract][Full Text] [Related]
20. Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibody.
Hanaoka H; Kuroki M; Yamaguchi A; Achmad A; Iida Y; Higuchi T; Oriuchi N; Tsushima Y; Endo K
Cancer Biother Radiopharm; 2014 Mar; 29(2):70-6. PubMed ID: 24299067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]